Zeus
Global leader in advanced polymer extrusion and catheter design manufacturing, specializing in mission-critical fluoropolymer components for medical devices, aerospace, and industrial applications.
- CEO / Founder
- Padraic "Paddy" O'Brien
- Team Size
- 1001-5000
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- Acquired
- Key Investors
- EQT
Technology & Products
Key Products
["Polymer Tubing (co-extrusions, convoluted, multi-lumen, heat-shrinkable)", "Catheter Components & End-to-End Catheter Manufacturing", "Biomaterials (Absorv™ bioabsorbable, Aeos™ ePTFE, Bioweb™ composites)", "Heat Shrink Tubing (FluoroPEELZ™, Dual-Shrink™)", "Insulated Wire & Filaments", "Reinforced Optical Fiber", "Custom Material Formulations"]
Technological Advantage
The company's ability to provide highly customized, high-performance polymer solutions gives it a significant advantage in markets with demanding applications and strict regulatory requirements.
Differentiation
Value Proposition
To provide innovative and dependable polymer solutions that meet the stringent requirements of its customers in critical applications.
How They Differentiate
Zeus differentiates through: (1) 60+ years of polymer extrusion expertise and material science leadership, (2) End-to-end catheter manufacturing from design to finished assemblies, (3) Global footprint with 13 facilities serving 100+ countries, (4) Deep R&D capabilities including NPD Accelerator Programs, (5) Broad material portfolio including proprietary biomaterials (Absorv™, Aeos™, Bioweb™).
Market & Competition
Target Customers
Leading medical device OEMs, contract manufacturing organizations (CMOs), aerospace manufacturers, automotive suppliers, semiconductor companies, and industrial customers requiring high-performance polymer solutions. Serves 300+ customers across 100+ countries globally.
Industry Verticals
["Medical (Cardiovascular, Neurovascular, Peripheral Intervention, Cardiac Rhythm Management, Gastrointestinal)", "Aerospace", "Automotive", "Energy", "Fiber Optics", "Semiconductors", "Fluid Management"]
Competitors
Teleflex Medical OEM", "Nordson MEDICAL", "Saint-Gobain Performance Plastics", "TE Connectivity", "Putnam Plastics", "Parker Hannifin
Growth & Milestones
Growth Metrics
Employee range: 1,000-5,000 as of August 29, 2025; locations include Orangeburg, SC; Matthews, SC; Branchburg, NJ; Chattanooga, TN; San Jose, CA; Arden Hills, MN; Guangzhou, China; Letterkenny, Ireland as of August 19, 2025; sale process rumors in September 2023 via Goldman Sachs with no completion details
Major Milestones
["1966: Founded by Frank P. Tourville Sr. in Orangeburg, South Carolina", "Expanded to 13 facilities worldwide (8 in US, Ireland, China)", "2024 April: Padraic 'Paddy' O'Brien appointed as CEO", "2024: Acquired by EQT Private Equity (EQT X fund) for approximately $3.4 billion", "2026: Celebrating 60 years of operation with major catheter material launch at MD&M West"]